Skip to main content
Fig. 4 | BMC Gastroenterology

Fig. 4

From: Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients

Fig. 4

Overall survival rate of autoimmune hepatitis patients with or without hepatocellular carcinoma. In the group without HCC, the median survival time (MST) was not achieved and the 1-year and 5-year survival rates were 96.2% and 94.7%, respectively. In the group with HCC, the MST was 7.5 years, and the 1-year and 5-year survival rates were 100% and 70.0%, respectively. HCC, hepatocellular carcinoma

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us